Control Bionics Ltd (CBL)

CBL Chart

vs Index S&P/ASX 20 S&P/ASX 50 S&P/ASX 100 S&P/ASX 200 S&P/ASX 300 All Ordinaries Small Ordinaries All Technology Consumer Staples Energy Financials Health Care Industrials Info Technology Materials Real Estate Comm. Services Utilities

Advanced

Show News Mov Avgs 9-day 10-day 20-day 30-day 50-day 100-day 150-day 200-day Mov Avgs 9-day 21-day 30-day 200-day Simple Exponential Weighted Simple Exponential Weighted vs Index S&P/ASX 20 S&P/ASX 50 S&P/ASX 100 S&P/ASX 200 S&P/ASX 300 All Ordinaries Small Ordinaries All Technology Consumer Staples Energy Financials Health Care Industrials Info Technology Materials Real Estate Comm. Services Utilities

Mov Avgs 10-day 20-day 30-day 50-day 100-day 150-day 200-day 9/21 Cross 10/30 Cross Golden Cross Vol RSI BB

Day 3m 6m 1yr 5yr 10yr

CBL's Principal Activity is the technology company that designs, manufactures and sells augmentative and alternative communication technology that allows users to operate and communicate via computer using their thoughts and neural signals.

Announcements

Company Overview

Dividend History

Ex-Date	Amount	Franking	Gross	Type	Payable
08/09/2017	$0.0135	0%	$0.0135	Interim	21/09/2017
13/03/2017	$0.0183	0%	$0.0183	Final	31/03/2017
27/10/2016	$0.0283	0%	$0.0283	Interim	04/11/2016
14/04/2016	$0.0404	0%	$0.0404	Final	22/04/2016

Show All

See Upcoming Dividends for all ASX companies.

Key Data
DPS(TTM)	$0.00
Gross DPS(TTM)	$0.00
Dividend yield
Gross yield
Payout Ratio	--
DRP	No
DRP Features	-

Directors & Management

Name	Title	Since	Bio
Mr Damian Lismore	Non-Executive Director	Sep 2020	Mr Damian Lismore Non-Executive Director Mr Lismore has held a number of Directorships and has commercial, international and listed company experience (both ASX and NASDAQ), covering many industries including healthcare and technology. In his executive career, he held CEO, CFO and Company Secretarial roles and continues to act as an advisor to CEOs, boards and business owners. Damian is currently CFO of Scout Bio Inc, a Frazier Healthcare Partners backed company, and a Non-Executive Director of ASX listed LBT Innovations Limited (ASX:LBT).He is also Chairman of Risk Committee of the CBL.
Mr Robert William Wong	Chief Executive Officer,Managing Director	Sep 2020	Mr Robert William Wong Chief Executive Officer,Managing Director Mr Wong has over 25 years of experience with multinational businesses in senior management and divisional operational roles. He has management experience in developing and commercialising technology products and services. Rob was appointed as CEO and Managing Director in January 2017. He also held the position of CEO at AIMIA Digital Industry Association of Australia. He is also member of Risk Committee of the CBL.
Mr Roger David Hawke	Non-Executive Chairman,Non-Executive Director	Sep 2018	Mr Roger David Hawke Non-Executive Chairman,Non-Executive Director Mr Hawke has over 30 years of experience in the telecommunications and technology space, having recently retired after 8 years as CEO & Managing Director of Crown Castle Australia/Axicom, and has experience particularly in Technology, Operations, Sales and Management. He is a Non-Executive Director of Infrastructure Logic Pty Ltd. He is also member of Risk Committee of the CBL.
Mr Lindsay John Phillips	Non-Executive Director	Aug 2014	Mr Lindsay John Phillips Non-Executive Director Mr Phillips has been involved in private equity for over 30 years, commencing in 1987 with M.J.H. Nightingale & Co. Limited in London/New York and subsequently Australia since 1995. His experience includes seven years (1980-87) with Price Waterhouse. Lindsay is currently Chairman of both Nightingale Partners and Phoenix Development Fund and serves as a Director on the majority of the funds' investee companies. Lindsay has been a Non-Executive Director of Control Bionics since August 2014. Lindsay has held a number of listed company board positions. He is currently chairman of Enprise Group Limited listed on NZX and has been a board member since December 2013. He was also previously chairman of Flat Glass Industries Limited from 2003 to 2015. He is also member of Risk Committee of the CBL.
Mr Peter Shann Ford	Executive Director	Jul 2005	Mr Peter Shann Ford Executive Director Mr Ford has began consulting to therapists and disability clients in innovative Assistive Technology, including bionics and robotics. After spending three years as a founding programmer at the Veterans Administration Medical Center Rehabilitation R&D Laboratory in Atlanta - one of the first of its kind in the USA - while a news anchor at CNN and CNN2. In 2000, Peter identified that a patients' disabled muscles still emitted small electrical signals that could be used to reliably control basic computer functions. Peter is the Company Founder and has been a Director of the Company since its incorporation in 2005. He is also member of Risk Committee of the CBL.
Mr Brett Thomas Crowley	Company Secretary	N/A

Show All

Director Transactions

Date	Director	Type	Amount	Price	Value	Notes
18/03/21	Damian Lismore	Buy	+25,000	$0.61	$15,250	On-market trade

Show All

Director Interests

Director	Last Notice	Direct Shares	Indirect Shares	Options	Convertibles
Damian Lismore	18/03/2021	N/A	55,000	N/A	N/A
Robert Wong	29/09/2020	N/A	2,540,616	3,365,678	N/A
Roger Hawke	19/09/2018	N/A	758,478	N/A	N/A
Lindsay Phillips	07/08/2014	N/A	17,195,676	N/A	N/A
Peter Ford	26/07/2005	21,258,313	N/A	3,567,860	N/A

Show All

Top 20 Shareholders About the Data

Name	Shares	Capital
Peter Shann Ford	21,258,313	25.51%
Nightingale Partners Pty Limited	9,117,123	10.94%
Phoenix Development Fund Limited	8,019,581	9.62%
National Nominees Limited	2,866,668	3.44%
BNP Paribas Noms Pty Ltd (Drp)	2,833,334	3.40%
Loidl Nominees Pty Ltd (Loidl Family A/C)	2,541,289	3.05%
R & R Wong Holdings Pty Limited (R & R Wong Family Super A/C)	2,540,616	3.05%
CS Third Nominees Pty Limited (HSBC Cust Nom Au Ltd 13 A/C)	2,500,000	3.00%
Pacific Atlantic Commerce Pty Ltd (Corcillum Superfund A/C)	1,424,366	1.71%
James Schorey	1,402,366	1.68%
Windward Capital Pty Ltd (S&L Rix Superfund A/C)	1,147,719	1.38%
Dowe Holdings Pty Limited	1,121,893	1.35%
HSBC Custody Nominees (Australia) Limited	1,018,334	1.22%
Santios Pty Limited (The Mcmurray Family A/C)	999,219	1.20%
Washington H Soul Pattinson And Company Limited	833,334	1.00%
Nandaroo Pty Ltd	792,202	0.95%
Robert Allwell Pty Ltd (Robert Allwell Superfund A/C)	781,757	0.94%
Paula Darling	781,757	0.94%
Hafnium Management Pty Ltd (Hafnium Family A/C)	758,478	0.91%
Paul Mahon	701,183	0.84%
Blacs Investment Group Pty Ltd (Blacs Two A/C)	670,987	0.81%

Show All

Shareholder Distribution

As reported in the most recent Annual Report.

Substantial Shareholders

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Share Price History

Date	Close	Change	%Chg	Open	High	Low	Volume	Turnover

Full Month

Historical Data

Year	Closing Price	Last Trade
No Financial Year End data available

CBL Historical Price Data (CSV)

Up to 20 years of EOD share price history

Sign up to Download

You must be logged in to access this feature. Please sign up for free or login.